Navigation Links
Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Ventrus Biosciences, Inc.
Date:5/10/2013

NEW YORK, May 10, 2013 /PRNewswire/ -- Bernstein Liebhard LLP today announced that a class action has been commenced in the United States District Court for the Southern District of New York on behalf of a class (the "Class") of purchasers of Ventrus Biosciences, Inc. ("Ventrus" or the "Company") (NASDAQ: VTUS) securities between December 17, 2010 and June 25, 2012 (the "Class Period").

(Logo: http://photos.prnewswire.com/prnh/20120202/MM47134LOGO

Ventrus is a development stage pharmaceutical company which is focused on late-stage prescription drugs for the treatment of gastrointestinal disorders, specifically hemorrhoids, anal fissures, and fecal incontinence.  Ventrus' lead products are topical treatments for hemorrhoids, which target a specific serotonin receptor.

Plaintiffs allege that, throughout the Class Period, the Company made false and/or misleading statements, as well as failed to disclose material adverse facts concerning the Company's lead product iferanserin (VEN 309) ("VEN 309").  The Company described VEN 309 as a new chemical entity for the topical treatment of symptomatic internal hemorrhoids.  The Company stated that in seven clinical studies between 1993 and 2003, VEN 309 demonstrated good tolerability and no severe adverse events while showing statistically significant improvements in bleeding, itchiness, and pain.

Specifically, during the Class Period the Company stated that it was in frequent and ongoing communications with the FDA, that clinical end points for the VEN 309 trial had been agreed to by the FDA, and that the prior results from Phase II trials of VEN 309 demonstrated the product's clinical efficacy. The Company represented its prior Phase I
'/>"/>

SOURCE Bernstein Liebhard LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bernstein Liebhard LLP Announces That A Securities Class Action Has Been Filed Against Aveo Pharmaceutical, Inc.
2. The law firms of Bernstein Litowitz Berger & Grossmann LLP and Labaton Sucharow LLP announce pendency of class action in In re Schering-Plough Corporation / ENHANCE Securities Litigation
3. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Abiomed, Inc.
4. Par Pharmaceutical Companies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG
5. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
6. Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
7. Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
8. Echo Therapeutics Announces First Quarter 2013 Financial Results
9. Life Care Medical Devices Ltd Announces Addition Of Dublin, Ireland Based European Subsidiary
10. Creabilis Announces Headline Results of its Phase 2b Trial of Topical TrkA Kinase Inhibitor CT327
11. Omeros Announces $16.2 Million Registered Direct Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015 The European ... defines and segments the concerned market in Europe ... non-invasive & minimally invasive cardiac output monitoring devices market in ... in 2014 and is estimated to grow to $89.8 million ... 2019. Browse through the TOC of European non-invasive ...
(Date:3/2/2015)... 2, 2015 Cure SMA recently announced a new ... Research (CALIBR). This funding is an extension of a spinal ... $700,000 Cure SMA grant to Dr. Peter G. Schultz ... of Small Molecules that Increase SMN2 Levels for ... neuron (SMN) protein is critical to the function of the ...
(Date:3/2/2015)... GLENWOOD, Ill. , March 2, 2015  Landauer, ... in personal and environmental radiation measurement and monitoring, outsourced ... today announced it will release financial results for the ... Monday, March 9, 2015. The Company ... Tuesday, March 10, 2015 at 9:00 a.m. Central Time ...
Breaking Medicine Technology:European Non-Invasive & Minimally Invasive Cardiac Output Monitoring Devices Market is Expected to Reach $89.8 Million by 2019, at a CAGR of 4.2% from 2014 to 2019 2European Non-Invasive & Minimally Invasive Cardiac Output Monitoring Devices Market is Expected to Reach $89.8 Million by 2019, at a CAGR of 4.2% from 2014 to 2019 3Cure SMA Announces $315,000 Grant to California Institute of Biomedical Research 2Cure SMA Announces $315,000 Grant to California Institute of Biomedical Research 3Landauer, Inc. Announces Date and Time for Announcement of Fiscal First Quarter 2015 Results and Conference Call 2
... Genprex, Inc. announced today that it will be presenting at ... San Francisco.   Greg Heinlein , Chief Operating and Financial Officer, ... Forum , on October 25 starting at 11 a.m. PDT in ... be made available on the company,s website under the News & ...
... CINCINNATI, Oct. 20, 2011 Prasco Laboratories , announced ... Eli Lilly and Company (NYSE: LLY ... Tablets and ZYPREXA® ZYDIS (olanzapine) Orally Disintegrating Tablets, in the ... products upon the first ANDA entrant into the market.  Prasco ...
Cached Medicine Technology:Genprex Presenting at 10th Annual BIO Investor Forum 2Prasco® Selected as Eli Lilly and Company's Authorized Generics Partner 2
(Date:3/3/2015)... 03, 2015 Motion 5 ... Environment from Pixel Film Studios. , “inMotion3D Environment is ... into 360° viewing area inside Motion 5” said Christina ... the line between professional and amateur making this plugin ... turn their 2D HDRI images into 360° viewing area ...
(Date:3/3/2015)... Salt Lake City, UT (PRWEB) March 03, 2015 ... is an innovative, user-friendly website that focuses ... wilderness therapy, therapeutic boarding schools, and addiction treatment ... Additionally, all residential interventions on the site ... assessments, anxiety, ADHD, autism spectrum disorders, severe learning ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Formetco today ... billboard design. The FTX uses state-of-the-art technology to ... performance reliability, and owner satisfaction. An item of ... the exclusive Formetco 10 year LED Brightness Warranty. , ... to be a superior billboard among any other billboard ...
(Date:3/2/2015)... 02, 2015 Today at the ... in partnership with the California Healthcare Institute (CHI) ... presented an Assembly resolution recognizing Feb. 28, 2015 ... healthcare professionals caring for millions of Californians living ... nonprofit, public policy research organization, representing leading California ...
(Date:3/2/2015)... 02, 2015 Cutler Integrative Medicine a ... the root, gives cutting-edge tips to bring about self-renewal. ... renew the body by first cleaning house. According ... “We are all Toxic.” Between environmental toxins like heavy ... greatness, and our high stress levels, we all have ...
Breaking Medicine News(10 mins):Health News:A New Plugin Entitled inMotion3D Environment Was Released Today from Pixel Film Studios Exclusively for Motion 5 2Health News:All Kinds of Therapy – New Website for Behavioral Health and Substance Abuse Treatment Launches Today 2Health News:Formetco Launches Innovative LED Billboard System 2Health News:California Healthcare Institute Spotlights Impact of Rare Diseases with Assemblymember Katcho Achadjian 2Health News:California Healthcare Institute Spotlights Impact of Rare Diseases with Assemblymember Katcho Achadjian 3Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2
... Cornell University and Dartmouth University have explained the biological ... why people get sleepy at night and wake ... transfers energy from light to chemical reactions in cells, ... even some forms of cancer in humans. ,Circadian ...
... in a gene called FGFR2 could accelerate the development ... uterine cancer. Researchers at Washington University School of Medicine ... (TGen); the Wellcome Trust Sanger Institute, which is part ... Medicine reported the findings in the May 21, 2007, ...
... Taubman lost a good friend to amyotrophic lateral sclerosis ... disease or ALS. ,The memory of watching ... condition has never left Mr. Taubmans mind. And that memory ... of Michigan Medical School and beyond. ,Now, he ...
... Army hospital here has conducted an accident victim's multiple organ ... to three individuals. ,The retrievals were conducted ... and the organs were transplanted Thursday on two patients at ... ,Donor Ramesh Chand, 60, whose two sons serve ...
... the DNA by Watson and Crick the imperious role ... been widely acknowledged. Genes produce an array of proteins, ... individuals functioning or, may coerce other genes to perform ... that adequate research is carried out to understand the ...
... team of engineers, scientists and clinicians from the ... could play a role in heart failure ... ,Patients who have the disease may have narrowed, ... blood flow is blocked and tiny blood clots ...
Cached Medicine News:Health News:Circadian Clocks Triggered Chemical Reactions may Be Behind Jet Lag 2Health News:Gene Discovery Lays Groundwork for Targeted Therapies for Endometrial Cancer 2Health News:Gene Discovery Lays Groundwork for Targeted Therapies for Endometrial Cancer 3Health News:$5M Gift Will Attack Lou Gehrig's Disease 2Health News:$5M Gift Will Attack Lou Gehrig's Disease 3Health News:Army Hospital Conducts First Multiple Organ Retrieval and Transplantation 2Health News:Drink, Binge and the Genetic Link 2Health News:Drink, Binge and the Genetic Link 3Health News:Research may Yield Improved Treatment for Diseased Lungs 2
Substrate Plasma for Factor VIII Assay by STA© Analyzers. Freeze-dried human plasma from which factor VIII has been removed by selective immuno-adsorption....
Substrate Plasma for Factor XI Assay by STA© Analyzers. Freeze-dried human plasma lacking factor XI....
Enzyme Immunoassay of von Willebrand Factor Antigenby ELISA Method, 96 tests....
Colorimetric Assay of Plasminogen Activity by STA© Analyzers....
Medicine Products: